Antonio Scalfari

12PUBLICATIONS
88CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)OrthopticsNeurology and neuromuscular diseasesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 06, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Benjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels

|May 01, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.

Damiano Marastoni, Elisa Colato, Matteo Foschi

|Apr 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study.

Paolo Antonio Muraro, Antonio Zito, Alessio Signori

|Jul 25, 2024
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.

Antonio Scalfari, Anthony Traboulsee, Jiwon Oh

|Apr 03, 2024
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.

Massimiliano Calabrese, Paolo Preziosa, Antonio Scalfari

|Mar 27, 2024
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.

Giulia Mallucci, Ottavia Eleonora Ferraro, Maria Trojano

Pageof 2

Frequent Collaborators

3 joint publications

Massimiliano Calabrese

2 joint publications

Gavin Giovannoni

2 joint publications

Roberta Magliozzi

2 joint publications

Richard Nicholas